托法替尼
溃疡性结肠炎
医学
Janus激酶抑制剂
维持疗法
诱导疗法
贾纳斯激酶
结肠炎
内科学
胃肠病学
化疗
受体
疾病
类风湿性关节炎
作者
William J. Sandborn,Chinyu Su,Bruce E. Sands,Geert R. D’Haens,Séverine Vermeire,Stefan Schreiber,Silvio Danese,Brian G. Feagan,Walter Reinisch,Wojciech Niezychowski,Gary S. Friedman,Nervin Lawendy,Dahong Yu,Deborah A. Woodworth,Arnab Mukherjee,Haiying Zhang,Paul J. Healey,Julián Panés
标识
DOI:10.1056/nejmoa1606910
摘要
Tofacitinib, an oral, small-molecule Janus kinase inhibitor, was shown to have potential efficacy as induction therapy for ulcerative colitis in a phase 2 trial. We further evaluated the efficacy of tofacitinib as induction and maintenance therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI